发明授权
US07524501B2 Methods of treating an injury to, or disorder of, the eye involving photoreceptor proliferation by administering VEGF2 antibodies
有权
通过施用VEGF2抗体治疗涉及光感受器增殖的眼睛的损伤或紊乱的方法
- 专利标题： Methods of treating an injury to, or disorder of, the eye involving photoreceptor proliferation by administering VEGF2 antibodies
- 专利标题（中）： 通过施用VEGF2抗体治疗涉及光感受器增殖的眼睛的损伤或紊乱的方法
-
申请号： US11078507申请日： 2005-03-14
-
公开(公告)号： US07524501B2公开(公告)日： 2009-04-28
- 发明人: Ralph Alderson , Robert Melder , Viktor Roschke , Steven M. Ruben , Craig A. Rosen
- 申请人： Ralph Alderson , Robert Melder , Viktor Roschke , Steven M. Ruben , Craig A. Rosen
- 申请人地址： US MD Rockville
- 专利权人： Human Genome Sciences, Inc.
- 当前专利权人： Human Genome Sciences, Inc.
- 当前专利权人地址： US MD Rockville
- 代理机构： Sterne, Kessler, Goldstein & Fox, P.L.L.C.
- 主分类号： A61K39/395
- IPC分类号： A61K39/395 ; A61K39/00
摘要：
The present invention is directed to VEGF-2 polynucleotides and polypeptides and methods of using such polynucleotides and polypeptides. In particular, provided are methods of treating retinal disorders with VEGF-2 polynucleotides and polypeptides.
公开/授权文献
- US20050181979A1 Vascular endothelial growth factor-2 公开/授权日：2005-08-18
信息查询
